Main InformationTargetCHMP6Host SpeciesRabbitReactivityHuman, MouseApplicationsWBMW22kD (Calculated)Conjugate/ModificationUnmodifiedDetailed InformationRecommended Dilution RatioWB 1:500-2000FormulationLiquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.SpecificityThis antibody detects endogenous levels of CHMP6 at Human/MousePurificationThe antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.Storage-15°C to -25°C/1 year(Do not lower than -25°C)Concentration1 mg/mlMW(Calculated)22kDModificationUnmodifiedClonalityPolyclonalIsotypeIgGAntigen&Target InformationImmunogen:Synthesized peptide derived from human CHMP6 AA range: 87-137Specificity:This antibody detects endogenous levels of CHMP6 at Human/MouseGene Name:CHMP6 VPS20Protein Name:CHMP6Background:This gene encodes a member of the chromatin-modifying protein/charged multivesicular body protein family. Proteins in this family are part of the ESCRT-III (endosomal sorting complex required for transport III) which degrades surface receptors, and in biosynthesis of endosomes. [provided by RefSeq, Mar 2012],Function:Domain:The acidic C-terminus and the basic N-termminus are thought to render the protein in a closed, soluble and inactive conformation through an autoinhibitory intramolecular interaction. The open and active conformation, which enables membrane binding and oligomerization, is achieved by interaction with other cellular binding partners, probably including other ESCRT components.,Function:Probable core component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and the budding of enveloped viruses (HIV-1 and other lentiviruses). ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4. In the ESCRT-III complex, it probably serves as an acceptor for the ESCRT-II complex on endosomal membranes.,similarity:Belongs to the SNF7 family.,subcellular location:Localizes to endosomal membranes.,subunit:Probable core component of the endosomal sorting required for transport complex III (ESCRT-III). ESCRT-III components are thought to multimerize to form a flat lattice on the perimeter membrane of the endosome. Several assembly forms of ESCRT-III may exist that interact and act sequentally. Interacts with VPS4A; the interaction is direct. Interacts with VPS4B; the interaction is direct. Interacts with CHMP4A, CHMP4B and CHMP4C. Interacts with SNF8, VPS25 and VPS36.,tissue specificity:Ubiquitously expressed.,Cellular Localization:Endomembrane system. Endosome membrane; Lipid-anchor. Late endosome membrane . Membrane ; Lipid-anchor . Localizes to endosomal membranes.Tissue Expression:Ubiquitously expressed.Research Areas:>>Viral life cycle - HIV-1 ; >>Endocytosis ; >>Necroptosis
商品信息已成功复制,启研竭诚为您服务
